Radiation-induced mitotic catastrophe in FANCD2 primary fibroblasts

References

• Alter BP. 2002. Radiosensitivity in Fanconi's anemia patients. Radiother Oncol 62:345–347.
   PubMed Web of Science ®Google Scholar
• Banath JP, Klokov D, MacPhail SH, Banuelos CA, Olive PL. 2010. Residual gammaH2AX foci as an indication of lethal DNA lesions. BMC Cancer 10:4.
   PubMed Web of Science ®Google Scholar
• Bigelow SB, Rary JM, Bender MA. 1979. G2 chromosomal radiosensitivity in Fanconi's anemia. Mutat Res 63:189–199.
   PubMedGoogle Scholar
• Bremer M, Schindler D, Gross M, Dork T, Morlot S, Karstens JH. 2003. Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy. Strahlenther Onkol 179:748–753.
   Google Scholar
• Chan KL, Palmai-Pallag T, Ying S, Hickson ID. 2009. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nature Cell Biol 11:753–760.
   PubMed Web of Science ®Google Scholar
• Cloos CR, Daniels DH, Kalen A, Matthews K, Du J, Goswami PC, Cullen JJ. 2009. Mitochondrial DNA depletion induces radioresistance by suppressing G2 checkpoint activation in human pancreatic cancer cells. Radiat Res 171:581–587.
   PubMed Web of Science ®Google Scholar
• D’Andrea AD. 2010. Susceptibility pathways in Fanconi's anemia and breast cancer. New Eng J Med 362:1909–1919.
   PubMed Web of Science ®Google Scholar
• Dickey JS, Redon CE, Nakamura AJ, Baird BJ, Sedelnikova OA, Bonner WM. 2009. H2AX: Functional roles and potential applications. Chromosoma 118:683–692.
   PubMedGoogle Scholar
• Djuzenova C, Flentje M, Plowman PN. 2004. Radiation response in vitro of fibroblasts from a fanconi anemia patient with marked clinical radiosensitivity. Strahlenther Onkol 180:789–797.
   Google Scholar
• Duckworth-Rysiecki G, Taylor AM. 1985. Effects of ionizing radiation on cells from Fanconi's anemia patients. Cancer Res 45:416–420.
   PubMed Web of Science ®Google Scholar
• Fenech M. 1993. The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 285:35–44.
   PubMed Web of Science ®Google Scholar
• Firat E, Gaedicke S, Tsurumi C, Esser N, Weyerbrock A, Niedermann G. 2011. Delayed cell death associated with mitotic catastrophe in gamma-irradiated stem-like glioma cells. Radiat Oncol 6:71.
   PubMed Web of Science ®Google Scholar
• Gallmeier E, Calhoun ES, Rago C, Brody JR, Cunningham SC, Hucl T, Gorospe M, Kohli M, Lengauer C, Kern SE. 2006. Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options. Gastroenterology 130:2145–2154.
   PubMed Web of Science ®Google Scholar
• Gluckman E. 1990. Radiosensitivity in Fanconi anemia: Application to the conditioning for bone marrow transplantation. Radiother Oncol 18(Suppl. 1):88–93.
   Google Scholar
• Hamasaki K, Imai K, Nakachi K, Takahashi N, Kodama Y, Kusunoki Y. 2007. Short-term culture and gammaH2AX flow cytometry determine differences in individual radiosensitivity in human peripheral T lymphocytes. Environ Molec Mutagen 48:38–47.
   PubMed Web of Science ®Google Scholar
• Higurashi M, Conen PE. 1973. In vitro chromosomal radiosensitivity in “chromosomal breakage syndromes”. Cancer 32:380–383.
   PubMedGoogle Scholar
• Hows JM, Chapple M, Marsh JC, Durrant S, Yin JL, Swirsky D, Gordon-Smith EC. 1989. Bone marrow transplantation for Fanconi's anaemia: The Hammersmith experience 1977–89. Bone Marrow Transplant 4:629–634.
   Google Scholar
• Huang X, Tran T, Zhang L, Hatcher R, Zhang P. 2005. DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. Proc Natl Acad Sci USA 102:1065–1070.
   PubMed Web of Science ®Google Scholar
• Hucl T, Rago C, Gallmeier E, Brody JR, Gorospe M, Kern SE. 2008. A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res 68:5023–5030.
   PubMed Web of Science ®Google Scholar
• Imreh G, Norberg HV, Imreh S, Zhivotovsky B. 2011. Chromosomal breaks during mitotic catastrophe trigger gammaH2AX-ATM- p53-mediated apoptosis. J Cell Sci 124:2951–2963.
   Google Scholar
• Joksic I, Vujic D, Guc-Scekic M, Leskovac A, Petrovic S, Ojani M, Trujillo JP, Surralles J, Zivkovic M, Stankovic A, Slijepcevic P, Joksic G. 2012. Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients. Genome Integrity 3:6.
   Google Scholar
• Kalb R, Duerr M, Wagner M, Herterich S, Gross M, Digweed M, Joenje H, Hoehn H, Schindler D. 2004. Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat Res 161:318–325.
   Google Scholar
• Kalb R, Neveling K, Hoehn H, Schneider H, Linka Y, Batish SD, Hunt C, Berwick M, Callen E, Surralles J, et al. 2007. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Human Genet 80: 895–910.
   PubMed Web of Science ®Google Scholar
• Klokov D, MacPhail SM, Banath JP, Byrne JP, Olive PL. 2006. Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother Oncol 80:223–229.
   PubMed Web of Science ®Google Scholar
• Kubbies M, Schindler D, Hoehn H, Schinzel A, Rabinovitch PS. 1985. Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells. Am J Human Genet 37:1022–1030.
   PubMedGoogle Scholar
• Kumari U, Ya Jun W, Huat Bay B, Lyakhovich A. 2013. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells. Oncogene 33:165–172.
   Google Scholar
• Leskovac A, Vujic D, Guc-Scekic M, Petrovic S, Joksic I, Slijepcevic P, Joksic G. 2010. Fanconi anemia is characterized by delayed repair kinetics of DNA double-strand breaks. Tohoku J Experim Med 221:69–76.
   Google Scholar
• Lyakhovich A. 2013. Damaged mitochondria and overproduction of ROS in Fanconi anemia cells. Rare Diseases 1:e24048.
   Google Scholar
• MacPhail SH, Banath JP, Yu Y, Chu E, Olive PL. 2003. Cell cycle- dependent expression of phosphorylated histone H2AX: Reduced expression in unirradiated but not X-irradiated G1-phase cells. Radiat Res 159:759–767.
   PubMed Web of Science ®Google Scholar
• Marcou Y, D’Andrea A, Jeggo PA, Plowman PN. 2001. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiother Oncol 60:75–79.
   PubMed Web of Science ®Google Scholar
• Mozdarani H. 2012. Biological complexities in radiation carcinogenesis and cancer radiotherapy: Impact of new biological paradigms. Genes 3:90–114.
   Web of Science ®Google Scholar
• Naim V, Rosselli F. 2009. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nature Cell Biol 11:761–768.
   PubMed Web of Science ®Google Scholar
• Okada H, Mak TW. 2004. Pathways of apoptotic and non-apoptotic death in tumour cells. Nature Rev Cancer 4:592–603.
   PubMed Web of Science ®Google Scholar
• Pagano G, Aiello Talamanca A, Castello G, Pallardo FV, Zatterale A, Degan P. 2012. Oxidative stress in Fanconi anaemia: From cells and molecules toward prospects in clinical management. Biolog Chem 393:11–21.
   PubMedGoogle Scholar
• Petrovic S, Leskovac A, Kotur-Stevuljevic J, Joksic J, Guc-Scekic M, Vujic D, Joksic G. 2011. Gender-related differences in the oxidant state of cells in Fanconi anemia heterozygotes. Biolog Chem 392:625–632.
   PubMedGoogle Scholar
• Rani R, Li J, Pang Q. 2008. Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice. Cancer Res 68:9693–9702.
   Google Scholar
• Sala-Trepat M, Rouillard D, Escarceller M, Laquerbe A, Moustacchi E, Papadopoulo D. 2000. Arrest of S-phase progression is impaired in Fanconi anemia cells. Experim Cell Res 260:208–215.
   PubMedGoogle Scholar
• Sasaki MS, Tonomura A. 1973. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 33:1829–1836.
   PubMed Web of Science ®Google Scholar
• Sobeck A, Stone S, Costanzo V, de Graaf B, Reuter T, de Winter J, Wallisch M, Akkari Y, Olson S, Wang W, Joenje H, Christian JL, Lupardus PJ, Cimprich KA, Gautier J, Hoatlin ME. 2006. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Molec Cellular Biol 26:425–437.
   PubMedGoogle Scholar
• Surralles J, Xamena N, Creus A, Marcos R. 1995. The suitability of the micronucleus assay in human lymphocytes as a new biomarker of excision repair. Mutat Res 342:43–59.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Suzuki K, Kodama S, Watanabe M. 2006. Phosphorylated histone H2AX foci persist on rejoined mitotic chromosomes in normal human diploid cells exposed to ionizing radiation. Radiat Res 165:269–276.
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, Lane WS, Kastan MB, D’Andrea AD. 2002. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109:459–472.
   PubMed Web of Science ®Google Scholar
• Vinciguerra P, Godinho SA, Parmar K, Pellman D, D’Andrea AD. 2010. Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J Clin Investig 120:3834–3842.
   PubMed Web of Science ®Google Scholar
• Yoshioka Y, Yamazaki H, Yoshida K, Ozeki S, Inoue T, Yoneda M. 2004. Impact of mitochondrial DNA on radiation sensitivity of transformed human fibroblast cells: Clonogenic survival, micronucleus formation and cellular ATP level. Radiat Res 162: 143–147.
   Google Scholar